Short Interest in Venus Concept Inc. (NASDAQ:VERO) Drops By 40.7%

Venus Concept Inc. (NASDAQ:VERO) was the target of a large drop in short interest in the month of August. As of August 15th, there was short interest totalling 91,500 shares, a drop of 40.7% from the July 31st total of 154,300 shares. Currently, 2.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,530,000 shares, the days-to-cover ratio is presently 0.1 days.

Venus Concept Price Performance

Venus Concept stock traded down $0.01 during mid-day trading on Friday, hitting $0.54. 31,563 shares of the company were exchanged, compared to its average volume of 807,862. The business’s 50 day simple moving average is $0.65 and its two-hundred day simple moving average is $0.73. The company has a market capitalization of $3.43 million, a P/E ratio of -0.08 and a beta of 0.53. Venus Concept has a 12-month low of $0.46 and a 12-month high of $2.44.

Insider Activity

In related news, major shareholder Michael Willingham Masters sold 102,717 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1.20, for a total value of $123,260.40. Following the completion of the transaction, the insider now directly owns 383,345 shares of the company’s stock, valued at approximately $460,014. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 51.39% of the company’s stock.

Institutional Investors Weigh In On Venus Concept

An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its holdings in shares of Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 as of its most recent SEC filing. Institutional investors and hedge funds own 87.41% of the company’s stock.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.